The Device
Colorectal cancer is a $4.5 billion crisis, with cases in adults under 55 doubling in the last decade. Surgical leaks are deadly and costly, adding $50,000 per patient in avoidable expenses. LeakGuard™ eliminates colostomy bags, shortens hospital stays, and prevents complications—driving massive savings for hospitals and insurers. The future of surgery is biodegradable, scalable, and investment-ready.
FDA Approved
The only designated FDA Breakthrough Device of its kind
Patented
Proprietary innovation transforming surgical care
Safer
Protects anastomosis during critical healing period
Biodegradable
Degrades and passes without need for removal
Simplifies Process
Obviates the need for a colostomy bag or any reversal
Pre-Clinical Study
(HOVER OVER IMAGES TO REVEAL MEDICAL CONTENT)
DAY 0
DAY 7
DAY 14
The Savings
The Savings
LeakGuard™ saves $20k-50k per patient
LeakGuard™ fits within the current DRGs for colorectal cancer
LeakGuard™ is likely eligible for New Technology Add On Payment (NTAP)
- No Colostomy
- No Additional Supplies
- No Reversal Surgery
- Reduced Hospital Stay
- Reduced OR Time